Lipid nanoparticles for cyclosporine A administration: development, characterization, and in vitro evaluation of their immunosuppression activity

Código QR

Lipid nanoparticles for cyclosporine A administration: development, characterization, and in vitro evaluation of their immunosuppression activity

Melissa Guada,1,2 Victor Sebastián,3,4 Silvia Irusta,3,4 Esperanza Feijoó,1 María del Carmen Dios-Viéitez,1 María José Blanco-Prieto1,2 1Department of Pharmacy and Pharmaceutical Technology, School of Pharmacy, University of Navarra,...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Guada M, Sebastián V, Irusta S, Feijoó E, Dios-Viéitez MC, Blanco-Prieto MJ
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2015
Materias:	Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/516968162d97414595bea3f5c8c18f62
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Preparation and in vitro and in vivo characterization of cyclosporin A-loaded, PEGylated chitosan-modified, lipid-based nanoparticles
por: Zhang L, et al.
Publicado: (2013)

Preparation and characterization of solid lipid nanoparticles containing cyclosporine by the emulsification-diffusion method
por: Zaida Urb&aacute;n-Morl&aacute;n, et al.
Publicado: (2010)

In vitro characterization and in vivo evaluation of nanostructured lipid curcumin carriers for intragastric administration
por: Fang M, et al.
Publicado: (2012)

Solid Lipid Nanoparticles of Mycophenolate Mofetil: An Attempt to Control the Release of an Immunosuppressant
por: Iqbal A, et al.
Publicado: (2020)

A new approach to the treatment of recurrent aphthous stomatitis with bioadhesive gels containing cyclosporine A solid lipid nanoparticles: in vivo/in vitro examinations
por: Karavana SY, et al.
Publicado: (2012)

Association of pro/anti-inflammatory cytokine gene variants in renal transplant patients with allograft outcome and cyclosporine immunosuppressant levels
por: Parmeet Kaur Manchanda, et al.
Publicado: (2008)

Lipid nanoparticles for topical and transdermal application for alopecia treatment: development, physicochemical characterization, and in vitro release and penetration studies
por: Gomes MJ, et al.
Publicado: (2014)

Solid self-nanoemulsifying cyclosporin A pellets prepared by fluid-bed coating: preparation, characterization and in vitro redispersibility
por: Lei Y, et al.
Publicado: (2011)

Solid Lipid Nanoparticles as Carriers for the Synthetic Opioid LP2: Characterization and In Vitro Release
por: Angelo Spadaro, et al.
Publicado: (2021)

In vitro Characterization and Release Studies of Combined Nonionic Surfactant-Based Vesicles for the Prolonged Delivery of an Immunosuppressant Model Drug
por: Rasul A, et al.
Publicado: (2020)

Solid and liquid lipid-based binary solid lipid nanoparticles of diacerein: in vitro evaluation of sustained release, simultaneous loading of gold nanoparticles, and potential thermoresponsive behavior
por: Rehman M, et al.
Publicado: (2015)

Cationic Solid Lipid Nanoparticles of Resveratrol for Hepatocellular Carcinoma Treatment: Systematic Optimization, in vitro Characterization and Preclinical Investigation
por: Rahman M, et al.
Publicado: (2020)

Characterization and in vivo evaluation of novel lipid&ndash;chlorambucil nanospheres prepared using a mixture of emulsifiers for parenteral administration
por: Honglin Song, et al.
Publicado: (2010)

Effect of Erythromycin on the Intestinal Transport of Cyclosporine
por: P Zakeri Milani,, et al.
Publicado: (2009)

Metabolic profile of puerarin in rats after intragastric administration of puerarin solid lipid nanoparticles
por: Luo CF, et al.
Publicado: (2013)

Novel formulation and evaluation of a Q10-loaded solid lipid nanoparticle cream: in vitro and in vivo studies
por: Farboud ES, et al.
Publicado: (2011)

A Review of the Mechanism of Action of Cyclosporine A: The Role of Cyclosporine A in Dry Eye Disease and Recent Formulation Developments
por: Periman LM, et al.
Publicado: (2020)

Silica nanoparticles trigger hepatic lipid-metabolism disorder in vivo and in vitro
por: Duan J, et al.
Publicado: (2018)

Treatment of chronic dry eye: focus on cyclosporine
por: George D Kymionis, et al.
Publicado: (2008)

Synthesis, characterization, and in vitro evaluation of novel polymer-coated magnetic nanoparticles for controlled delivery of doxorubicin
por: Akbarzadeh A, et al.
Publicado: (2012)

Preparation, characterization and in-vitro evaluation of sustained release protein-loaded nanoparticles based on biodegradable polymers
por: Biswajit Mukherjee, et al.
Publicado: (2008)

Synthesis, characterization, and in vitro evaluation of curcumin-loaded albumin nanoparticles surface-functionalized with glycyrrhetinic acid
por: Li J, et al.
Publicado: (2015)

Preparation, characterization, and optimization of primaquine-loaded solid lipid nanoparticles
por: Omwoyo WN, et al.
Publicado: (2014)

An Evaluation of the in vivo Safety of Nonporous Silica Nanoparticles: Ocular Topical Administration versus Oral Administration
por: Martha Kim, et al.
Publicado: (2017)

Ionization and structural properties of mRNA lipid nanoparticles influence expression in intramuscular and intravascular administration
por: Manuel J. Carrasco, et al.
Publicado: (2021)

Solid lipid nanoparticles modified with stearic acid&ndash;octaarginine for oral administration of insulin
por: Zhang ZH, et al.
Publicado: (2012)

Preparation of Curcumin Solid Lipid Nanoparticles Loaded with Flower-Shaped Lactose for Lung Inhalation and Preliminary Evaluation of Cytotoxicity In Vitro
por: Nan Li, et al.
Publicado: (2021)

Formulation, characterization, and evaluation of in vitro skin permeation and in vivo pharmacodynamics of surface-charged tripterine-loaded nanostructured lipid carriers
por: Chen Y, et al.
Publicado: (2012)

Encapsulated Escitalopram and Paroxetine Intranasal Co-Administration: In Vitro/In Vivo Evaluation
por: Soraia Silva, et al.
Publicado: (2021)

Enhancement of physicochemical properties of nanocolloidal carrier loaded with cyclosporine for topical treatment of psoriasis: in vitro diffusion and in vivo hydrating action
por: Musa SH, et al.
Publicado: (2017)

Synthesis, characterization, and in vitro evaluation of novel polymer-coated magnetic nanoparticles for controlled delivery of doxorubicin [Retraction]
por: Akbarzadeh A, et al.
Publicado: (2019)

Conductive polymer-based nanoparticles for laser-mediated photothermal ablation of cancer: synthesis, characterization, and in vitro evaluation
por: Cantu T, et al.
Publicado: (2017)

CuO Nanoparticles : Biosynthesis, Characterization and In Vitro Study
por: Ahmad Fatoni, et al.
Publicado: (2021)

Assessment to the Antifungal Effects in vitro and the Ocular Pharmacokinetics of Solid-Lipid Nanoparticle in Rabbits
por: Liang Z, et al.
Publicado: (2021)

Thymoquinone-loaded nanostructured lipid carriers: preparation, gastroprotection, in vitro toxicity, and pharmacokinetic properties after extravascular administration
por: Abdelwahab SI, et al.
Publicado: (2013)

Formulation design, characterization, and in vitro and in vivo evaluation of nanostructured lipid carriers containing a bile salt for oral delivery of gypenosides
por: Yang G, et al.
Publicado: (2019)

Characterization, pharmacokinetics, and hypoglycemic effect of berberine loaded solid lipid nanoparticles
por: Xue M, et al.
Publicado: (2013)

Preparation and characterization of solid lipid nanoparticles loaded with frankincense and myrrh oil
por: Shi F, et al.
Publicado: (2012)

Cyclosporine A micellar delivery system for dry eyes
por: Kang H, et al.
Publicado: (2016)

Novel cationic lipid nanoparticles as an ophthalmic delivery system for multicomponent drugs: development, characterization, in vitro permeation, in vivo pharmacokinetic, and molecular dynamics studies
por: Wang J, et al.
Publicado: (2017)